X0508 4 2025-04-29 0000785161 Encompass Health Corp EHC 0001186879 COLTHARP DOUGLAS E 9001 LIBERTY PARKWAY BIRMINGHAM AL 35242 1 EVP & Chief Financial Officer 0 Encompass Health Common Stock 2025-04-29 4 M 0 16075 29.06 A 76410 D Encompass Health Common Stock 2025-04-29 4 M 0 27500 32.94 A 103910 D Encompass Health Common Stock 2025-04-29 4 S 0 26239 114.78 D 77671 D Encompass Health Common Stock 2025-04-29 4 S 0 13402 115.51 D 64269 D Encompass Health Common Stock 2025-04-29 4 S 0 3934 116.36 D 60335 D Encompass Health Common Stock 125631 I By irrevocable trust for the benefit of children Encompass Health Common Stock 65229 I By spouse Non-qualified Stock Option (Right to Buy) 29.06 2025-04-29 4 M 0 16075 0 D 2017-02-26 2026-02-26 Encompass Health Common Stock 16075 0 D Non-qualified Stock Option (Right to Buy) 32.94 2025-04-29 4 M 0 27500 0 D 2019-10-28 2026-10-28 Encompass Health Common Stock 27500 27694 D This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.22 to $115.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.22 to $116.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.22 to $116.57, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. /s/ Patrick Darby, attorney-in-fact for Mr. Coltharp 2025-04-30